Prevalence of Ever-Diagnosed ASD 2.79 Percent in U.S. Children

The prevalence of ever-diagnosed autism spectrum disorder (ASD) is 2.79 percent in the United States, with state-level variations in prevalence, according to a study published online Dec. 3 in JAMA Pediatrics.
Guifeng Xu, M.D., from the University of Iowa in Iowa City, and colleagues used cross-sectional data from the 2016 National Survey of Children's Health to estimate the prevalence and treatment patterns of ASD among young children. Data were included for 43,032 children aged 3 to 17 years and were obtained from questionnaires completed by a parent or guardian.
The researchers found the weighted prevalence of ever-diagnosed and current ASD was 2.79 and 2.50 percent, respectively. There was variation in the state-level prevalence of ever-diagnosed ASD from 1.54 percent in Texas to 4.88 percent in Florida. About 70 percent of children with current ASD were treated nationally: 43.3, 6.9, and 20.3 percent received behavioral treatment only, medication only, and both behavioral and medication treatments, respectively; 29.5 percent did not receive behavioral or medication treatment.
"Continued monitoring of the prevalence and treatment of ASD is warranted," the authors write. "Future research and policy efforts are critically needed to understand and address the barriers for children with ASD to receive appropriate treatments."
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
After 20 Years of Negotiations, 90% of Tariffs to Be Cut! EU and Mercosur Sign Free Trade Agreement: Trade Barriers Ease, Transatlantic Cooperation Warms Up?
-
Rising Naphtha Prices in Japan Drive Up Costs for Diapers, Sanitary Products, and Cosmetics
-
Global Chemical Inventories Hit Critical Lows as Over 200 Chinese Companies Suspend Quotations
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment
-
Arkema and ENNEX Forge Global Alliance to Power the Next Generation of Safer, Smarter Battery Separators
-
French Cosmetics Exports Poised for First Drop in Over Two Decades in 2025
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
Recommend Reading
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
Premium Global Chemical Sourcing Requests (17 - 22 Jan, 2026)
-
Supply-Demand Mismatch: Acrylonitrile Market Stagnant and Relatively Weak in May
-
Spread Widens as Shandong Cyclohexanone Market Prices Continue to Decline in May
-
Lithium Carbonate May Remain in a Volatile Range in June